Suan Farma, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States, with significant operations across Europe and Latin America. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Suan Farma's core offerings include a diverse range of products tailored for various therapeutic areas, distinguished by their commitment to innovation and regulatory compliance. The company has achieved notable milestones, including strategic partnerships and expansions that enhance its market position. With a focus on sustainability and quality, Suan Farma continues to make significant contributions to the global healthcare landscape, reinforcing its reputation as a trusted provider in the pharmaceutical sector.
How does Suan Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Suan Farma's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Suan Farma, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Suan Farma may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate impact. However, without specific emissions data or reduction initiatives, it is unclear how Suan Farma aligns with these industry trends. As the company moves forward, establishing measurable climate commitments could enhance its sustainability profile and contribute to broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Suan Farma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
